N6022 Chemical Properties

Boiling point:

662.7±55.0 °C(Predicted)

Density 

1.30±0.1 g/cm3(Predicted)

storage temp. 

-20° C

solubility 

Soluble in DMSO (up to at least 25 mg/ml).

form 

solid

pka

4.63±0.10(Predicted)

color 

White

Stability:

Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 2 months.

N6022 Usage And Synthesis

Description

N6022 (1208315-24-5) is a potent and reversible inhibitor of S-nitrosoglutathione reductase (GSNOR) – IC50?= 20 nM1, 8 nM2. It demonstrated significant efficacy in mouse models of ovalbumin-induced asthma, chronic obstructive pulmonary disease, and irritable bowel syndrome. N6022 was able to attenuate experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis)?via?selective inhibition of pro-inflammatory CD4+?cells (TH1/TH17) while upregulating anti-inflammatory subsets of CD4+?cells (TH2/Treg) without causing lymphopenia.3

Uses

N6022 is a tight-binding, specific, and fully reversible inhibitor of S-nitrosoglutathione reductase.

References

1) Sun?et al.?(2011),?Discovery of s-nitrosoglutathione reductase inhibitors: potential agents for the treatment of asthma and other inflammatory diseases; ACS Med. Chem. Lett.?2?402 2) Green?et al.?(2012),?Mechanism of inhibition for N6022, a first-in-class drug targeting S-nitrosoglutathione reductase; Biochemistry?51?2157 3) Saxena?et al.?(20198),?S-Nitrosoglutathione reductase (GSNOR) inhibitor as an immune modulator in experimental autoimmune encephalomyelitis; Free Radic. Biol. Med.?121?57

N6022(1208315-24-5)Related Product Information

• VU0134992(hydrochloride)
• VU6012962
• VU0810464
• VU6015929
• VU0238441
• N-(4-Chloro-3-methoxyphenyl)-2-pyridinecarboxamide
• 1-(4-Methoxybenzyl)-5-trifluoromethoxyisatin
• VUN65671
• VU 0357121
• VU6010608
• VU 0364439
• VU-29
• 3-METHYLADENINE
• Bortezomib
• Infigratinib
• Rapamycin
• VU 0364770
• VU 0357017 hydrochloride